%0杂志文章%@ 1438- 8871% I JMIR出版物%V 22卡塔尔世界杯8强波胆分析% N 6% P e15372% T糖尿病患者使用移动个人健康记录调节血红蛋白A1c:回顾性观察研究%A Seo,Dongjin %A Park,Yu Rang %A Lee,Yura %A Kim,Ji Young %A Park,Joong-Yeol %A Lee,Jae-Ho %+蔚山大学医学院峨山医疗中心信息医学系，首尔松坡区奥林匹克路43吉88号，05505，大韩民国，82 230103350，rufiji@gmail.com %K个人健康记录%K移动健康%K电子病历%K糖尿病%K糖化血红蛋白A %D 2020 %7 2.6.2020 %9原始论文%J J医学互联网Res %G英文%X背景:个人健康记录(PHRs)在糖尿病管理中的有效性已在多项临床试验中得到验证;然而，在现实场景中证明它们的有效性也是必要的。为了提供可靠的真实世界证据，应该进行比仅基于患者生成的健康数据的分析更准确的分析。目的:本研究旨在更准确地分析电子病历(EMRs)中使用PHRs的有效性。这项研究的结果将为PHRs作为可行的糖尿病管理工具提供精确的现实世界证据。方法:我们收集了2015年12月至2018年4月韩国首尔峨山医疗中心(AMC)的My Chart in My Hand version 2.0 (MCMH 2.0)应用程序中糖函数的日志数据。收集AMC MCMH 2.0用户的EMR数据，并与PHR数据进行整合。我们根据用户是否持续使用应用进行分类。 We analyzed and compared their characteristics, patterns of hemoglobin A1c (HbA1c) levels, and the proportion of successful HbA1c control. The following confounders were adjusted for HbA1c pattern analysis and HbA1c regulation proportion comparison: age, sex, first HbA1c measurement, diabetes complications severity index score, sugar function data generation weeks, HbA1c measurement weeks before MCMH 2.0 start, and generated sugar function data count. Results: The total number of MCMH 2.0 users was 64,932, with 7453 users having appropriate PHRs and diabetes criteria. The number of continuous and noncontinuous users was 133 and 7320, respectively. Compared with noncontinuous users, continuous users were younger (P<.001) and had a higher male proportion (P<.001). Furthermore, continuous users had more frequent HbA1c measurements (P=.007), shorter HbA1c measurement days (P=.04), and a shorter period between the first HbA1c measurement and MCMH 2.0 start (P<.001). Diabetes severity–related factors were not statistically significantly different between the two groups. Continuous users had a higher decrease in HbA1c (P=.02) and a higher proportion of regulation of HbA1c levels to the target level (P=.01). After adjusting the confounders, continuous users had more decline in HbA1c levels than noncontinuous users (P=.047). Of the users who had a first HbA1c measurement higher than 6.5% (111 continuous users and 5716 noncontinuous users), continuous users had better regulation of HbA1c levels with regard to the target level, 6.5%, which was statistically significant (P=.04). Conclusions: By integrating and analyzing patient- and clinically generated data, we demonstrated that the continuous use of PHRs improved diabetes management outcomes. In addition, the HbA1c reduction pattern was prominent in the PHR continuous user group. Although the continued use of PHRs has proven to be effective in managing diabetes, further evaluation of its effectiveness for various diseases and a study on PHR adherence are also required. %M 32484447 %R 10.2196/15372 %U //www.mybigtv.com/2020/6/e15372 %U https://doi.org/10.2196/15372 %U http://www.ncbi.nlm.nih.gov/pubmed/32484447